Equities

Sigma Koki Co Ltd

7713:TYO

Sigma Koki Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,453.00
  • Today's Change-5.00 / -0.34%
  • Shares traded26.70k
  • 1 Year change-1.69%
  • Beta0.9097
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of May 31 2024202420232022
ASSETS
Cash And Short Term Investments6,4976,9235,728
Total Receivables, Net2,8092,9183,063
Total Inventory3,0083,2842,667
Prepaid expenses------
Other current assets, total220126131
Total current assets12,53413,25211,589
Property, plant & equipment, net4,7563,8813,579
Goodwill, net------
Intangibles, net6380103
Long term investments2,9282,6942,705
Note receivable - long term------
Other long term assets366377253
Total assets20,94520,63418,510
LIABILITIES
Accounts payable1,2861,2931,314
Accrued expenses204035
Notes payable/short-term debt000
Current portion long-term debt/capital leases304402249
Other current liabilities, total1,1591,307936
Total current liabilities2,7693,0422,534
Total long term debt204417162
Total debt508818411
Deferred income tax------
Minority interest959084
Other liabilities, total830843848
Total liabilities3,8974,3923,628
SHAREHOLDERS EQUITY
Common stock2,6232,6232,623
Additional paid-in capital3,0923,0923,092
Retained earnings (accumulated deficit)10,72610,3439,133
Treasury stock - common(634)(634)(634)
Unrealized gain (loss)236190239
Other equity, total1,005628429
Total equity17,04816,24214,882
Total liabilities & shareholders' equity20,94520,63418,510
Total common shares outstanding7.087.087.08
Treasury shares - common primary issue0.470.470.47
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.